ADVERTISEMENT
Latest Blogs, Articles, and More
Opdivo Receives Priority Review for Non-Small Cell Lung Cancer
The Food and Drug Administration (FDA) has granted a priority review to Opdivo for use in patients with previously treated, advanced, squamous non-small cell lung cancer (NSCLC). A decision will be made by June 22, 2015.
Transplant And Beyond
Now that the big day has arrived, what happens next? It may not be as exciting as advertised.
Experts Examine and Discuss the ER-Positive Breast Cancer Treatment Landscape
The management of patients with hormone receptor (HR)-positive breast cancer continues to evolve, with phase 3 studies shedding light on the length of adjuvant anti-estrogen therapy, a novel treatment gaining approval, and new trials exploring combination strategies.
We Are The 30%
Metastatic breast cancer will strike 30% of all breast cancer survivors yet only 2% of funds go to research this deadly cancer.
The Mechanics Of Inspiration
Being offered the chance to be an inspiration isn't up to you. What you do with it afterwards, is.
Special Feature
ADVERTISEMENT
Recent Publications
  • photo
    photo
    photo
    photo
    photo
  • photo
    photo
    photo
    photo
    photo
ADVERTISEMENT
$auto_registration$